Italy Elevator and Escalator - Market Size & Growth Forecast 2023-2029

Italy Elevator and Escalator - Market Size & Growth Forecast 2023-2029

The Italy elevator and escalator market is expected to grow at a CAGR of 2.41% during 2023-2029.

MARKET OUTLOOK

The increasing demand for high-rise structures and the government's focus on infrastructure in key economic cities have propelled the Italy elevator and escalator market to new heights.

The Italy elevator market by the installed base is expected to reach 1,126,423 units by 2029. In 2022, elevators used in the residential sector accounted for the largest share of around 38.6%, applicable to Italy's steadily increasing urban population. The rising use of elevators in apartment buildings significantly impacts their adoption in the residential sector.

Growth Rate Of Digitalization And Increasing Developments In Buildings To Drive The Italy Elevator And Escalator Market

  • Home transactions have witnessed an increase of 43.1% in 2021. It is observed that housing purchases rose in smaller cities, towns, or the countryside in 2021 by 46.6% and in major cities by 36.1%. Increasing sales growth in smaller towns/cities or suburbs is contributed by the pandemic, which has stimulated demand for better access to living spaces, according to ANCE (Associazione Nazionale Costruttori Edili).
  • An investment of USD 41.7 million was invested in meeting the demand of Milan for developing long-term rental and social housing. Further, a residential project of 200 apartments project was planned in the Sarpi Area of Milan.
  • Nearly USD 30.8 million was allocated to energy efficiency projects and building redevelopment as a key investment in saving 0.98Mt CO2 by anticipating reduction through energy efficiency in public and private buildings.
KEY HIGHLIGHTS
  • Unity of Japanese engineer Hitachi and Italian contractors Webuild and Astaldi had been awarded a contract worth USD 2.8 billion in August 2020 to begin initial works on Verona-Padua high-speed/high-capacity railway project in Italy with an allocated fund of USD 5.4 billion. The project is anticipated to be finished by 2027 and will enhance the development of the infrastructure sector in Italy.
  • Ministry of Infrastructure had allocated USD 8.4 million towards mobility, water resources, housing, and urban renewal. In addition, another USD 661 million was financed for the “Caput Mundi” project, which was initiated by the Ministry of Tourism.
  • An estimated investment of around USD 312.6 million for a new logistics project is planned for Verona, Italy. The project is located in Vigasio and will be in two phases; an investment of USD 12.5 million is estimated to construct four buildings in an area of 200,000 m2. The project's second phase will involve an additional investment of USD 18.8 million. The initial phase is expected to be finished by 2023.
  • To promote increased tourist flows and enable the area's commercial fabric and community centers to resume, a moving walkway, also known as a sliding sidewalk, was installed in the tunnel between Rome's Via Nazionale and Via del Tritone. The Termini-Vatican-Aurelio tramway will pass across Via Nazionale on the Jubilee of 2025. The authority anticipates that increased pedestrian and tourist traffic will result from the upgraded infrastructure.
  • Under Italy’s Budget Law 2021, funding of USD 33.3billion was allotted to Infrastructure 4.0 investment, USD 29.5billion for high-speed railway and road maintenance, and USD 38.5 was funded to intermodal transport and integrated logistics for the development of non-residential and infrastructure construction in Italy.
  • The Milan-Cortina 2026 Winter Olympics are the city's next major international event and are expected to be a successful operation, a fundamental demonstration for Italy. It's an opportunity to enhance Cortina's infrastructure, which is one of its drawbacks, and to attract international tourists.
  • Three million tons of carbon dioxide per year will be reduced by the Turin-Lyon railway by 2030. The Trans-European Transport Network (TEN-T) is building a railway between Turin and Lyon under the Alps. Webuild and its joint venture (JV) partners have been awarded a contract for excavating a section of the base tunnel for the Turin-Lyon high-speed train worth USD 1.69 billion (€1.43 billion).
SEGMENTATION

Elevator Market Segmentation by

Machine Type
  • Hydraulic and Pneumatic
  • Machine Room Traction
  • Machine Room Less Traction
  • Others
  • Climbing
  • Elevators
  • Industrial Elevators
Carriage Type
  • Passenger
  • Freight
Capacity
  • 2-15 Persons
  • 16-24 Persons
  • 25-33 Persons
  • 34 Persons and Above
End-User
  • Commercial
  • Residential
  • Industrial
  • Others
  • Public Transit
  • Institutional
  • Infrastructural
Escalator Market Segmentation by

Product Type
  • Parallel
  • Multi Parallel
  • Walkway
  • Crisscross
End-User
  • Public Transit
  • Commercial
  • Others
  • Institutional Sector
  • Infrastructure
  • Industrial
Governments Effort To Expand Infrastructure Across Nation To Increase Demand For New Installations
  • Italy will likely invest USD 7.8 billion to modernize and increase capacity at its docks until 2026. The funding is mainly focused on increasing the size of the ships that Italy’s leading container ports can handle through dredging, new breakwaters, and improved connections to road and rail links.
  • The government of Italy allocated USD 4.1 billion towards mobility in 2022. Out of this funding, USD 2.1 billion will be utilized for local lines and high-speed rail and around USD 1.7 billion for rapid mass transport such as metros and subways, also upgrading the bus fleet in Rome.
  • The train run time between the Brescia-Verona-Vicenza line will be reduced by 2026 as the line between Liguria, and Alpi will compete. The upgradation of the Verona to Brennero line will also be witnessed with a value of USD 8.9 billion.
  • In Bentivoglio, part of the Bologna Freight Village complex, Italy, to design and construct three new turnkey logistics buildings. Three structures with floor areas of 12,340 m2, 18,200 m2, and 16,700 m2 are involved. Each building will have functional office space, a warehouse, and technical facilities. Since the corporation is committed to sustainability, these buildings will be LEED Silver certified.
Regulation-Driven Maintenance And Modernization of Elevators And Escalators In Italy To Create Demand
  • The maintenance and modernization of Italy elevator and escalator market accounted for 67.9% and 32.1%, respectively, for 2022.
  • According to ThyssenKrupp Elevator Italia, around 40% of the total building stock has crossed the threshold age of 30 years. Various technological advancements have made machine users more functional and economical from an energy perspective. They also need to satisfy EU regulations by sector, which is essential.
  • SMI (Scale Mobili Italia) is focused on the maintenance and service of mobility equipment, including elevators, escalators, and moving walkways. In 2018 it introduced training sessions and courses on the maintenance of escalators for technicians in elevator companies where they get to explore procedures for maintenance, modernization, and replacement of multi-brand escalators. This is expected to support the Italy elevator and escalator market growth during the forecast period.
REGIONAL ANALYSIS
  • The completion of metro line C will mark Rome's infrastructure revival with a budgeted price of USD 7 billion has been set out for this project. The line, built by a group of businesses that includes the Webuild Group, is one of the significant essential infrastructures in the capital because it runs from the edge of the city into the historic center.
  • Milan will be one of Europe's most modernized cities, with more public and private developments and an anticipated USD 13 billion investment by 2030 (including USD 2 billion for public urbanization projects). Additionally, the housing industry in Milan will add 33,000 units by 2030, accommodating 100,000 people. Such investment initiatives are expected to support the Italy elevator and escalator market.
VENDOR LANDSCAPE
  • The top 4 prominent vendors, including Otis, KONE, Schindler, and TK Elevator, account for 60% of the Italy elevator and escalator market share.
  • In June 2021, Otis Elevator introduced the next-generation Gen3 elevator at the Alexander tower, Germany. The smart Gen3 elevator adds built-in Otis ONE Internet of Things (IoT) connectivity to the proven flat-belt technology of the Gen2 elevator.
  • TK Elevator launched its global spare parts strategy with the inauguration of its first Smart Data technological warehouse; a new state-of-the-art warehouse in Spain reduces waiting times for elevator spare parts by 20% and saves 10% of all trips by service technicians.
  • Continue rolling out digital products like MAX and implementing dedicated initiatives such as SPBE(Spare Parts Business Excellence) to enhance efficiency and help reduce emissions remain Mitsubishi Electric's strengths.
Key Vendors
  • Otis
  • KONE
  • Schindler
  • TK Elevator
  • Mitsubishi Electric
  • Fujitec
Other Prominent Vendors
  • Stannah Lifts Holdings Ltd
  • GMV Lifts
  • Cibes Lift Group
  • Giovenzana
  • Wittur
KEY QUESTIONS ANSWERED

1. How big is the Italy elevator and escalator market?

2. What will be the growth rate of the Italy elevator and escalator market?

3. What is the number of installed bases in the Italy elevators and escalators market in 2029?

4. Who are the key companies in the Italy elevator and escalator market?

5. What factors drive the maintenance and modernization segment in the Italy elevator and escalator market?


1. HEPATOCELLULAR CARCINOMA OVERVIEW
1.1. Hepatocellular Carcinoma (HCC) – An Overview
2. HEPATOCELLULAR CARCINOMA EPIDEMIOLOGY & OVERVIEW
2.1. 8MM: Historic & Projected Volume of Incidence & Prevalence of HCC
2.2. 8MM: Comparative Analysis of Incidence & Prevalence of HCC
2.3. 8MM: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.4. 8MM: Comparative Analysis of Incidence of HCC cases by Age Group
2.5. US: Historic & Projected Volume of Incidence & Prevalence of HCC
2.6. US: Comparative Analysis of Incidence & Prevalence of HCC
2.7. US: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.8. US: Comparative Analysis of Incidence of HCC cases by Age Group
2.9. China: Historic & Projected Volume of Incidence & Prevalence of HCC
2.10. China: Comparative Analysis of Incidence & Prevalence of HCC
2.11. China: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.12. China: Comparative Analysis of Incidence of HCC cases by Age Group
2.13. Japan: Historic & Projected Volume of Incidence & Prevalence of HCC
2.14. Japan: Comparative Analysis of Incidence & Prevalence of HCC
2.15. Japan: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.16. Japan: Comparative Analysis of Incidence of HCC cases by Age Group
2.17. Germany: Historic & Projected Volume of Incidence & Prevalence of HCC
2.18. Germany: Comparative Analysis of Incidence & Prevalence of HCC
2.19. Germany: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.20. Germany: Comparative Analysis of Incidence of HCC cases by Age Group
2.21. UK: Historic & Projected Volume of Incidence & Prevalence of HCC
2.22. UK: Comparative Analysis of Incidence & Prevalence of HCC
2.23. UK: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.24. UK: Comparative Analysis of Incidence of HCC cases by Age Group
2.25. France: Historic & Projected Volume of Incidence & Prevalence of HCC
2.26. France: Comparative Analysis of Incidence & Prevalence of HCC
2.27. France: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.28. France: Comparative Analysis of Incidence of HCC cases by Age Group
2.29. Italy: Historic & Projected Volume of Incidence & Prevalence of HCC
2.30. Italy: Comparative Analysis of Incidence & Prevalence of HCC
2.31. Italy: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.32. Italy: Comparative Analysis of Incidence of HCC cases by Age Group
2.33. Spain: Historic & Projected Volume of Incidence & Prevalence of HCC
2.34. Spain: Comparative Analysis of Incidence & Prevalence of HCC
2.35. Spain: Historic & Projected Volume of Incidence of HCC cases by Age Group
2.36. Spain: Comparative Analysis of Incidence of HCC cases by Age Group
3. HEPATOCELLULAR CARCINOMA MARKET SIZE & OVERVIEW
3.1. 8MM: Historic & Projected Revenue of HCC
3.2. 8MM: Historic & Projected Revenue of HCC Snapshot
3.3. 8MM: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.4. US: Historic & Projected Revenue of HCC
3.5. US: Historic & Projected Revenue of HCC Snapshot
3.6. US: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.7. China: Historic & Projected Revenue of HCC
3.8. China: Historic & Projected Revenue of HCC Snapshot
3.9. China: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.10. Japan: Historic & Projected Revenue of HCC
3.11. Japan: Historic & Projected Revenue of HCC Snapshot
3.12. Japan: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.13. Germany: Historic & Projected Revenue of HCC
3.14. Germany: Historic & Projected Revenue of HCC Snapshot
3.15. Germany: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.16. UK: Historic & Projected Revenue of HCC
3.17. UK: Historic & Projected Revenue of HCC Snapshot
3.18. UK: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.19. France: Historic & Projected Revenue of HCC
3.20. France: Historic & Projected Revenue of HCC Snapshot
3.21. France: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.22. Italy: Historic & Projected Revenue of HCC
3.23. Italy: Historic & Projected Revenue of HCC Snapshot
3.24. Italy: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
3.25. Spain: Historic & Projected Revenue of HCC
3.26. Spain: Historic & Projected Revenue of HCC Snapshot
3.27. Spain: Historic & Projected Revenue Segmentation by Gender Type, Age Group & Drug Class
4. HEPATOCELLULAR CARCINOMA MARKETED DRUGS OVERVIEW
4.1. Hepatocellular Carcinoma Marketed Drugs – An Overview
4.2. Hepatocellular Carcinoma Marketed Drugs – Summary
5. HEPATOCELLULAR CARCINOMA PIPELINE DRUGS OVERVIEW
5.1. HCC Pipeline Drugs – An Overview
5.2. HCC Pipeline Drugs – Snapshot
5.3. Pipeline Drugs Overview & Snapshot – By Disease type
5.4. HCC Pipeline Drugs Overview & Snapshot – By Development Phase
5.5. HCC Pipeline Drugs Overview & Snapshot – By Route of Administration
5.6. HCC Pipeline Drugs Overview & Snapshot – By Mechanism of Action
5.7. HCC Pipeline Drugs Overview & Snapshot – By Molecule type
5.8. HCC Pipeline Drugs Overview & Snapshot – By Geography type
6. HEPATOCELLULAR CARCINOMA CLINICAL TRIALS OVERVIEW
6.1. HCC Clinical Trials Overview Snapshot
6.2. HCC Clinical Trials Overview – By Recruitment Status
6.3. HCC Clinical Trials Overview – By Product type
6.4. HCC Clinical Trials Overview – By Route of Administration
6.5. HCC Clinical Trials Overview – By Molecule type
6.6. HCC Clinical Trials Overview – By Geography type
7. HEPATOCELLULAR CARCINOMA MARKET DYNAMICS
7.1. HCC Therapeutics Market Drivers
7.2. HCC Therapeutics Market Constraints
7.3. HCC Therapeutics Market Trends
8. HEPATOCELLULAR CARCINOMA COMPETITIVE LANDSCAPE
8.1. HCC Competitive Landscape – Marketed Drugs
8.2. Key Company Profiles
8.3. Other Key Company Profiles
8.4. Competitive Scenario of HCC therapeutics market
8.5. Key Company Overviews
8.6. Hepatocellular Carcinoma Competitive Landscape – Pipeline Drugs
8.7. Key Emerging Company Profiles
8.8. Other Key Emerging Company Profiles
8.9. Key Company Overviews
9. HEPATOCELLULAR CARCINOMA MISCELLANEOUS
9.1. Key Tentative Drug Approvals Timeline
9.2. Key Regulatory Designations
9.3. Key Milestones
9.4. Deals & Collaborations
9.5. Inactive/Discontinued/Dormant Products
9.6. Unmet needs/Strategic Recommendations
10. APPENDIX
10.1. About Arizton
10.2. Research Methodology
10.3. List of Abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings